Valuation: RaySearch Laboratories AB

Market Cap 6.57B 690M 598M 559M 511M 961M 65.84B 977M 2.57B 32.9B 2.59B 2.53B 111B P/E 2026 *
24.6x
P/E 2027 * 20.1x
Enterprise Value 6.73B 708M 613M 573M 524M 985M 67.54B 1B 2.64B 33.74B 2.66B 2.6B 114B EV / Sales 2026 *
4.82x
EV / Sales 2027 * 4.04x
Free-Float
80.09%
Yield 2026 *
2.09%
Yield 2027 * 2.49%
1 day+2.02%
1 week+9.43%
Current month+6.86%
1 month-18.16%
3 months+4.70%
6 months+5.57%
Current year-16.01%
1 week 172.6
Extreme 172.6
194.4
1 month 153.1
Extreme 153.1
235.4
Current year 153.1
Extreme 153.1
238.4
1 year 153.1
Extreme 153.1
301.5
3 years 63
Extreme 63
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 1999-12-31
Director of Finance/CFO 48 2025-01-26
Chief Tech/Sci/R&D Officer 53 2015-08-27
Director TitleAgeSince
Director/Board Member 57 1999-12-31
Chairman 81 2016-11-17
Chairman 87 2022-09-29
Date Insider Type Main position Quantity % Market Cap.
6/11/26 Buy

General Counsel

462 0.0015%
12/17/25 Fiscal year

Founder

1,021,577 12.0826%
12/17/25 Fiscal year

Founder

1,021,577 3.5685%
Change 5-day change 1-year change 3-year change Capi.($)
+2.02%+9.43%-36.27%+169.72% 678M
+0.81%+14.71%-16.15%+22.80% 38.12B
+3.24%+10.71%-40.90%+160.69% 13.04B
+0.07%+1.19%-22.20%+65.67% 5.5B
+0.65%+10.39%+2.75% - 2.53B
-3.06%-0.49% - - 1.89B
-1.21%-2.10%+19.56%-42.59% 1.7B
-2.17%-1.60%-34.15% - 1.06B
+1.74%+7.11%+37.35%+126.70% 907M
-0.27%+2.22%-32.48%-46.82% 847M
Average +0.18%+99.64%-13.61%+65.17% 6.63B
Weighted average by Cap. +1.02%+189.90%-19.96%+56.63%

Financials

2026 *2027 *
Net sales 1.4B 147M 127M 119M 109M 204M 14B 208M 547M 7B 551M 539M 23.55B 1.63B 171M 148M 139M 127M 239M 16.35B 243M 638M 8.17B 644M 629M 27.5B
Net income 265M 27.85M 24.13M 22.57M 20.61M 38.78M 2.66B 39.45M 104M 1.33B 105M 102M 4.47B 320M 33.63M 29.13M 27.25M 24.89M 46.83M 3.21B 47.64M 125M 1.6B 126M 124M 5.4B
Net Debt 169M 17.76M 15.39M 14.39M 13.14M 24.73M 1.69B 25.16M 66.17M 847M 66.72M 65.24M 2.85B 25M 2.63M 2.28M 2.13M 1.94M 3.66M 251M 3.72M 9.79M 125M 9.87M 9.65M 422M
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
26-08-11 SEK 191.50 +2.02% 280,997
26-08-10 SEK 187.70 +4.34% 745,726
26-08-07 SEK 179.90 +1.93% 146,809
26-08-06 SEK 176.50 +1.73% 96,393
26-08-05 SEK 173.50 -1.87% 229,032
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
191.50SEK
Average target price
310.00SEK
Spread / Average Target
+61.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RAY B Stock